Northwest Biotherapeutics

September 14, 2016

Cancer Immunotherapy: A Developmental Timeline & Examination of the Prior Art Paradox

[vc_row][vc_column][vc_column_text]The American Society of Clinical Oncology (ASCO) recently named cancer immunotherapy as the 2016 Advance of the Year, with President Dr. Julie Vose noting that “no […]